Back to Journals » OncoTargets and Therapy » Volume 9

JAK2 inhibitor combined with DC-activated AFP-specific T-cells enhances antitumor function in a Fas/FasL signal-independent pathway

Total article views   HTML views PDF downloads Totals
5,986 Dovepress* 5,368+ 1,265 6,633
PubMed Central* 618 148 766
Totals 5,986 1,413 7,399
*Since 20 July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar